MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ALKS
  4. News
Investor Relations
ALKS
Quote
Short
News
Articles
Message Board

Alkermes plc (NASDAQ : ALKS ) News

News Releases

ALKS News Releases
ALKS : NASDAQ
SeekingAlpha
Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
ALKS : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Morning edition
Wed, Jun 24, 2026 as of 10.00 am ET
ALKS : NASDAQ
SeekingAlpha
Alkermes: 'Buy' On Avadel Acquisition And Positive NT2 Data With Alixorexton
ALKS : NASDAQ
SeekingAlpha
Alkermes plummets on mid-stage alixorexton data for narcolepsy
ALKS : NASDAQ
Business Wire
Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026
ALKS : NASDAQ
Business Wire
Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe
ALKS : NASDAQ
SeekingAlpha
Alkermes' alixorexton gains FDA orphan drug status for idiopathic hypersomnia
ALKS : NASDAQ
SeekingAlpha
Alkermes plc (ALKS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
ALKS : NASDAQ
Business Wire
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research
ALKS : NASDAQ
Business Wire
Alkermes to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.